Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antithrombotic treatment and atrial fibrillation.

Literature DB >> 1493385

Antithrombotic treatment and atrial fibrillation.

G D Lowe.

Abstract

Entities: Disease

Mesh：

Substances：
Warfarin

Year: 1992 PMID： 1493385 PMCID： PMC1884122 DOI： 10.1136/bmj.305.6867.1445

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

12 in total

1. Randomized trials of warfarin for atrial fibrillation.

Authors: D E Singer
Journal: N Engl J Med Date: 1992-11-12 Impact factor: 91.245

Review 2. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.

Authors: P Sandercock; R Lindley; J Wardlaw
Journal: Br J Hosp Med Date: 1992 May 20-Jun 2

3. Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis.

Authors: M D Walker
Journal: Lancet Date: 1989-02-11 Impact factor: 79.321

4. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors: P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal: Lancet Date: 1989-01-28 Impact factor: 79.321

5. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors: S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal: J Am Coll Cardiol Date: 1991-08 Impact factor: 24.094

6. Relation of atrial fibrillation and high haematocrit to mortality in acute stroke.

Authors: G D Lowe; A J Jaap; C D Forbes
Journal: Lancet Date: 1983-04-09 Impact factor: 79.321

7. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors: P A Wolf; R D Abbott; W B Kannel
Journal: Stroke Date: 1991-08 Impact factor: 7.914

8. Duration of atrial fibrillation and imminence of stroke: the Framingham study.

Authors: P A Wolf; W B Kannel; D L McGee; S L Meeks; N E Bharucha; P M McNamara
Journal: Stroke Date: 1983 Sep-Oct Impact factor: 7.914

9. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.

Authors: J I Sage; R L Van Uitert
Journal: Stroke Date: 1983 Jul-Aug Impact factor: 7.914

10. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Authors: P Sandercock; J Bamford; M Dennis; J Burn; J Slattery; L Jones; S Boonyakarnkul; C Warlow
Journal: BMJ Date: 1992-12-12

19 in total

4. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.

Authors: D A Fitzmaurice; E T Murray; K M Gee; T F Allan; F D R Hobbs
Journal: J Clin Pathol Date: 2002-11 Impact factor: 3.411

Antithrombotic treatment and atrial fibrillation.

1. Randomized trials of warfarin for atrial fibrillation.

Review 2. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.

3. Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis.

4. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

5. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

6. Relation of atrial fibrillation and high haematocrit to mortality in acute stroke.

7. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

8. Duration of atrial fibrillation and imminence of stroke: the Framingham study.

9. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.

10. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

1. Recommendations for patients undertaking self management of oral anticoagulation.

2. Patient self management of oral anticoagulation in routine care in the UK.

Review 3. Oral anticoagulation control: the European perspective.

4. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.

Review 5. Cardioversion of atrial fibrillation.

6. Antithrombotic treatment and atrial fibrillation.

7. Antithrombotic treatment and atrial fibrillation.

8. Survey of use of anticoagulation in patients with atrial fibrillation.

9. Methods for managing the increased workload in anticoagulant clinics.

10. Treatment of atrial fibrillation in a district general hospital.